Legal & General Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.27M Buy
123,348
+6,172
+5% +$164K ﹤0.01% 1752
2025
Q1
$2.83M Buy
117,176
+9,806
+9% +$237K ﹤0.01% 1794
2024
Q4
$4.32M Sell
107,370
-745
-0.7% -$30K ﹤0.01% 1650
2024
Q3
$6.84M Buy
108,115
+6,606
+7% +$418K ﹤0.01% 1413
2024
Q2
$5.38M Buy
101,509
+5,222
+5% +$277K ﹤0.01% 1489
2024
Q1
$7.9M Buy
96,287
+781
+0.8% +$64K ﹤0.01% 1274
2023
Q4
$1.78M Buy
95,506
+906
+1% +$16.9K ﹤0.01% 2003
2023
Q3
$1.05M Sell
94,600
-202
-0.2% -$2.24K ﹤0.01% 2169
2023
Q2
$1.54M Buy
94,802
+64,493
+213% +$1.05M ﹤0.01% 2042
2023
Q1
$505K Buy
+30,309
New +$505K ﹤0.01% 2314
2022
Q2
Sell
-24,729
Closed -$74K 3664
2022
Q1
$74K Hold
24,729
﹤0.01% 2931
2021
Q4
$114K Hold
24,729
﹤0.01% 2883
2021
Q3
$156K Buy
24,729
+13,023
+111% +$82.2K ﹤0.01% 2753
2021
Q2
$70K Buy
11,706
+528
+5% +$3.16K ﹤0.01% 2848
2021
Q1
$70K Buy
11,178
+3,899
+54% +$24.4K ﹤0.01% 2722
2020
Q4
$41K Hold
7,279
﹤0.01% 2857
2020
Q3
$42K Sell
7,279
-2,677
-27% -$15.4K ﹤0.01% 2752
2020
Q2
$72K Buy
9,956
+594
+6% +$4.3K ﹤0.01% 2620
2020
Q1
$44K Sell
9,362
-3,326
-26% -$15.6K ﹤0.01% 2636
2019
Q4
$102K Buy
12,688
+981
+8% +$7.89K ﹤0.01% 2588
2019
Q3
$81K Hold
11,707
﹤0.01% 2591
2019
Q2
$98K Hold
11,707
﹤0.01% 2539
2019
Q1
$116K Buy
11,707
+1,003
+9% +$9.94K ﹤0.01% 2449
2018
Q4
$82K Buy
10,704
+2,945
+38% +$22.6K ﹤0.01% 2509
2018
Q3
$135K Buy
7,759
+1,264
+19% +$22K ﹤0.01% 2426
2018
Q2
$62K Buy
+6,495
New +$62K ﹤0.01% 2659